Projects (1159)
Cardiff University Schools involved in this Project
A randomised double blind placebo controlled phase II study of fulvestrant with or without the addition of vandetanib as treatment for patients with metastatic breast cancer resistant to aromatase inhibitor therapy - FURVA AZ (01/10/2014 - 14/09/2024)
- Casbard, Angela
- A randomised double blind placebo controlled phase II study of fulvestrant with or without the addition of vandetanib as treatment for patients with metastatic breast cancer resistant to aromatase inhibitor therapy - FURVA CRUK
(01/10/2014 - 30/09/2017)- Casbard, Angela
A randomised, double blind, placebo-controlled study of RAD001 (Everolimus) in the treatment of neurocognitive problems in tuberous sclerosis (01/09/2011 - 30/09/2018)
- Sampson, Julian
-
- Rosser, Anne
A randomised feasibility study of a school-based emotional literacy programme (Zippy's Friends) for children with intellectual disabilities (01/03/2020 - 31/01/2023)
- Mcnamara, Rachel
A randomised feasibility study to evaluate home-based personalised virtual reality physiotherapy rehabilitation compared to usual care in the treatment of pain for people with knee osteoarthritis (01/12/2022 - 30/11/2025)
- Al-Amri, Mohammad
A randomised, multicentre, open label, non-inferiority study of ACP-196 versus ibrutinib in previously treated subjects with high risk chronic lymphocytic leukaemia (30/06/2016 - 31/12/2021)
- Fegan, Christopher
A randomised multicentre, open label, phase 3 clinical trial to evaluate the efficacy, safety and PK of prophylactic RC5534262 versus no prophylaxis in haemophilia A patients with inhibitors (12/02/2016 - 31/03/2018)
- Collins, Peter
A randomised, multicentre, open-label, phase III clinical trial to evaluate the efficacy, safety and pharmacokinetics of prophylactic Emicizumab verse no prophylaxics in haemophilia A patients without inhibitors (05/10/2016 - 31/10/2018)
- Collins, Peter
A randomised phase 2/3 study of DACOGEN (Decitabine) plus JNJ-56022473 (Anti CD223) versus DACOGEN (Decitabine) alone in patients with AML who are not candidates for intensive chemotherapy (06/12/2016 - 31/12/2018)
- Knapper, Steven